Accelerating Rare Disease Diagnosis and Treatment
3X Genetics is a molecular diagnostics company that is accelerating the diagnosis and treatment of rare genetic diseases, with an initial focus on Repeat Expansion Disorders (REDs). We have developed breakthrough tests and tools that deliver high-precision results. We collaborate with patients, biopharma, clinicians, and researchers to advance the understanding and treatment of rare genetic diseases.
Who We Serve
Researchers
Per-molecule repeat distributions and a genotype report for every sample, with no PCR at any step. Research use only.
Learn moreSponsors
Genetic characterization for DM1 trials and registries, returned as one integrated record per participant.
Learn moreClinicians
TCF4 and DM1 tests are in analytical validation. Leave your details to be notified when ordering opens.
Learn moreMD Families
Discounted or free testing for people who have, or suspect they have, myotonic dystrophy, starting with a confidential meeting with a genetic counselor.
Learn more- CLIA-registered laboratoryCLIA-ID 22D2345868, Leominster, MA. Massachusetts certification pending.
- Single-molecule reads, no PCRRepeat count, sequence and methylation are called for every read, straight from native DNA.
- DM1 white paper, April 202614 subjects and about 1,800 individually sequenced molecules, compared across three independent methods.